Global Health Limited
Symbool: MEDANTA.NS
NSE
1407
INRMarktprijs vandaag
83.0259
Koers/Winst Verhouding
0.0000
Koers/Winst Groei Verhouding
377.79B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Global Health Limited (MEDANTA-NS) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 13107.8 | 5118.1 | 2893 | |||||
balance-sheet.row.short-term-investments | 0 | 5435.4 | 3923.8 | 2198.3 | |||||
balance-sheet.row.net-receivables | 0 | 1942 | 2423.8 | 1655 | |||||
balance-sheet.row.inventory | 0 | 603.7 | 533.9 | 397.6 | |||||
balance-sheet.row.other-current-assets | 0 | 141.3 | 41.5 | 1730.7 | |||||
balance-sheet.row.total-current-assets | 0 | 15794.9 | 8117.2 | 5021.3 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 23719 | 22088.5 | 20722.4 | |||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.intangible-assets | 0 | 51.7 | 62.7 | 72.5 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 51.7 | 62.7 | 72.5 | |||||
balance-sheet.row.long-term-investments | 0 | -5005.5 | -3818.9 | -2009.8 | |||||
balance-sheet.row.tax-assets | 0 | 257.1 | 277.9 | 257.4 | |||||
balance-sheet.row.other-non-current-assets | 0 | 6342.6 | 4727.8 | 2877.2 | |||||
balance-sheet.row.total-non-current-assets | 0 | 25364.8 | 23337.9 | 21919.7 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 41159.6 | 31455.2 | 26941 | |||||
balance-sheet.row.account-payables | 0 | 1946.9 | 1343.3 | 1315.5 | |||||
balance-sheet.row.short-term-debt | 0 | 1393.6 | 1055.9 | 1029.5 | |||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.long-term-debt-total | 0 | 9825.9 | 10033.3 | 8284.2 | |||||
Deferred Revenue Non Current | 0 | 669.7 | 218.7 | 363.4 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 983.5 | 23.7 | 14.1 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 11152 | 11100.3 | 9071 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 2797.3 | 2710.6 | 2867.8 | |||||
balance-sheet.row.total-liab | 0 | 16877.6 | 15295.1 | 13117.6 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 325 | |||||
balance-sheet.row.common-stock | 0 | 536.4 | 506.4 | 820.9 | |||||
balance-sheet.row.retained-earnings | 0 | 12837.9 | 9529.6 | 7689.8 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 237.3 | 274.5 | 442.5 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | 10670.5 | 5849.6 | 4545.2 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 24282.1 | 16160.1 | 13823.4 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 41159.6 | 31455.2 | 26941 | |||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-equity | 0 | 24282.1 | 16160.1 | 13823.4 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 429.9 | 104.9 | 188.6 | |||||
balance-sheet.row.total-debt | 0 | 11219.5 | 11089.3 | 9313.8 | |||||
balance-sheet.row.net-debt | 0 | 3547.1 | 9894.9 | 8619.1 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 4492.9 | 2805.6 | 324.6 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 1499.1 | 1297.1 | 1232.1 | |||||
cash-flows.row.deferred-income-tax | 0 | -7.5 | -874.5 | 131.7 | |||||
cash-flows.row.stock-based-compensation | 0 | 7.5 | 17.4 | 37.9 | |||||
cash-flows.row.change-in-working-capital | 0 | 1028.2 | -667.7 | 365.9 | |||||
cash-flows.row.account-receivables | 0 | -214.6 | -495.6 | 102.9 | |||||
cash-flows.row.inventory | 0 | -69.8 | -136.3 | -12.4 | |||||
cash-flows.row.account-payables | 0 | 603.6 | 27.8 | 8.1 | |||||
cash-flows.row.other-working-capital | 0 | 709 | -63.5 | 267.4 | |||||
cash-flows.row.other-non-cash-items | 0 | -582.6 | 534.7 | 325.4 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -2359.9 | -2744.8 | -1457.4 | |||||
cash-flows.row.acquisitions-net | 0 | 8 | 13.8 | 38 | |||||
cash-flows.row.purchases-of-investments | 0 | -1416.1 | -1725.4 | -1172.8 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | -8 | 83.7 | 50.4 | |||||
cash-flows.row.other-investing-activites | 0 | 352.5 | 163.8 | 150.3 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -3423.4 | -4208.9 | -2391.5 | |||||
cash-flows.row.debt-repayment | 0 | -666.5 | -198.9 | -30.2 | |||||
cash-flows.row.common-stock-issued | 0 | 4785.5 | 379.5 | 2.4 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||
cash-flows.row.other-financing-activites | 0 | -662.6 | 1415.2 | -779.4 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 3456.4 | 1595.9 | -807.2 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||
cash-flows.row.net-change-in-cash | 0 | 6478.1 | 499.7 | -781 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 7672.4 | 1194.3 | 694.7 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1194.3 | 694.7 | 1475.7 | |||||
cash-flows.row.operating-cash-flow | 0 | 6445.2 | 3112.6 | 2417.7 | |||||
cash-flows.row.capital-expenditure | 0 | -2359.9 | -2744.8 | -1457.4 | |||||
cash-flows.row.free-cash-flow | 0 | 4085.3 | 367.9 | 960.3 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 26942.5 | 21559.7 | 14306.1 | |||||
income-statement-row.row.cost-of-revenue | 0 | 6252.8 | 5429.3 | 3485.6 | |||||
income-statement-row.row.gross-profit | 0 | 20689.6 | 16130.4 | 10820.6 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | 649.1 | 122.4 | 80 | |||||
income-statement-row.row.operating-expenses | 0 | 15990.5 | 12730.5 | 9893.6 | |||||
income-statement-row.row.cost-and-expenses | 0 | 22243.3 | 18159.8 | 13379.2 | |||||
income-statement-row.row.interest-income | 0 | 346.2 | 167.2 | 177.6 | |||||
income-statement-row.row.interest-expense | 0 | 779.2 | 789.5 | 671 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -855.4 | -594.3 | -602.3 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | 649.1 | 122.4 | 80 | |||||
income-statement-row.row.total-operating-expenses | 0 | -855.4 | -594.3 | -602.3 | |||||
income-statement-row.row.interest-expense | 0 | 779.2 | 789.5 | 671 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | 1499.1 | 1297.1 | 1232.1 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | 5348.3 | 3399.9 | 927 | |||||
income-statement-row.row.income-before-tax | 0 | 4492.9 | 2805.6 | 324.6 | |||||
income-statement-row.row.income-tax-expense | 0 | 1232.1 | 843.6 | 36.6 | |||||
income-statement-row.row.net-income | 0 | 3260.8 | 1962 | 288.1 |
Vaak gestelde vragen
Wat is Global Health Limited (MEDANTA.NS) totale activa?
Global Health Limited (MEDANTA.NS) totale activa is 41159640000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.768.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.143.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.226.
Wat is Global Health Limited (MEDANTA.NS) nettowinst (netto-inkomen)?
De nettowinst is 3260793000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 11219519000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 15990499000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.